Suppr超能文献

经尿道前列腺切除术术中 void 评分作为疗效标志物的作用:一项可行性研究。

The role of intra-operative void score during transurethral resection of prostate as a marker of efficacy: a feasibility study.

机构信息

Dunedin Hospital, Southern District Health Board, Dunedin, New Zealand.

Biostatistics Centre, Division of Health Sciences, University of Otago, Dunedin, New Zealand.

出版信息

ANZ J Surg. 2022 Jun;92(6):1492-1497. doi: 10.1111/ans.17664. Epub 2022 Mar 30.

Abstract

BACKGROUND

To assess the feasibility of a novel intra-operative void scoring technique. To determine if intra-operative void score (VS) could act as a marker for post-operative success following TURP.

METHODS

Fifteen patients undergoing TURP were included in this single-centre feasibility study. All patients had indwelling urinary catheters for recurrent retention due to benign prostatic hyperplasia (BPH). In theatre, immediately before- and after TURP, an intra-operative VS was measured and graded 0-5. Primary outcomes were the feasibility of measuring intra-operative VS and its accuracy in predicting surgical outcome.

RESULTS

A combined pre- and post-score with a threshold ≥6 correctly predicted 82% of those who were catheter free (sensitivity) and 100% of those who were not catheter free (specificity) at follow up and the positive predictive value was 100% and negative predictive value 60%.

CONCLUSION

Intra-operative void score during TURP is simple, reproducible, fast and requires minimal resources. In TURP it may predict successful outcomes by identifying patients who will be catheter free post-operatively as opposed to those who will be catheter dependent despite the procedure.

摘要

背景

评估一种新型术中排空评分技术的可行性。确定术中排空评分(VS)是否可以作为 TURP 后术后成功的标志物。

方法

本单中心可行性研究纳入了 15 例因良性前列腺增生(BPH)而反复发生潴留需要留置导尿管的接受 TURP 的患者。在手术室中,在 TURP 前后立即测量并分级 0-5 分的术中 VS。主要结局是测量术中 VS 的可行性及其预测手术结果的准确性。

结果

联合术前和术后评分,阈值≥6 分可正确预测 82%的无导尿管患者(敏感性)和 100%的仍需导尿管患者(特异性)在随访时的情况,阳性预测值为 100%,阴性预测值为 60%。

结论

TURP 期间的术中排空评分简单、可重复、快速且所需资源最少。在 TURP 中,它可以通过识别术后无需导尿管的患者来预测手术成功,而不是识别那些尽管进行了手术但仍需要导尿管的患者。

相似文献

3
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.

本文引用的文献

6
Outcome of surgery for benign prostatic hyperplasia-is it predictable?
J Clin Diagn Res. 2013 Dec;7(12):2859-62. doi: 10.7860/JCDR/2013/7606.3888. Epub 2013 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验